Research summaries for everyoneNot medical advice
5-Amino-1MQ research reference vial, Elevated Pharma

Research reference · Weight & Metabolism

5-Amino-1MQ

5-Amino-1MQ is a small-molecule inhibitor of the enzyme NNMT, not a peptide. Its published record is small and preclinical.

Published by Elevated Pharma ·

Weight & MetabolismPreclinical literature

Identity

What is 5-Amino-1MQ?

5-amino-1-methylquinolinium; the counter-ion (often iodide) must be specified to define the material.

Research context

What has 5-Amino-1MQ been studied for?

Enzyme, cell and mouse studies of NNMT inhibition, plus a rat pharmacokinetic method paper. No human trial was found.

Evidence boundary

What does the research not show?

The free cation and the iodide salt have different formulas and masses and are not interchangeable.

U.S. status · November 7, 2026

Is 5-Amino-1MQ FDA-approved?

Not FDA-approved. No human safety conclusion or permitted-use claim is made.

Key studies

The main 5-Amino-1MQ research

Selected from PubMed: human trials first, then reviews, then foundational laboratory work. Each finding applies to the material and setting studied.

Search all PubMed records for 5-Amino-1MQ · Counts and selections checked November 7, 2026.

Reference identifiers

5-Amino-1MQ identity data

Database identity describes the reference substance, not any specific material or lot.

Primary name
5-Amino-1MQ
Also indexed as
5-Amino-1-methylquinolinium / 5-Amino-1-methylquinolinium iodide
Molecular formula
C10H11IN2
Molecular mass
286.11 g/mol
PubChem CID
66522933

Official & primary sources

Regulatory and database records

Citation does not imply an Elevated Pharma partnership or endorsement.